OVERVIEW

Immunology

As a complex network of cells and proteins throughout the body, the immune system helps our body to defend itself against infections.

In some cases, the immune system can be over-active, resulting in an excessive immune response against substances in the environment (such as with allergic reactions) or a response to normal components of the body (such as in autoimmune diseases). 

Researchers at TRI are studying the processes behind immunological disorders such as autoimmune disorders and bone and joint disorders, and ways we can train the immune system to target cancer cells via immunotherapies.

Image: Lymphocyte illustration (Big Stock Photo: urfingus ID123040430)

Key Researchers
 
Tim Wells
Allison Pettit
Antje Blumenthal
David Evans
Graham Robert Leggatt
Kristen Radford
Matthew Arthur Brown
Michael McGuckin
Ranjeny Thomas
Raymond John Steptoe
Stephen Robert Mattarollo
Show More ...
IMMUNOLOGY RESEARCH PROGRAMS
Click a program below to learn more
 
Autoimmune and Autoinflammatory Diseases
Bone and Joint Diseases
Immunotherapies
Inflammatory Bowel Disease
Article
A drug currently in clinical trials has the potential to improve the survival rate of Australians diagnosed with acute myeloid leukaemia, following the outcomes of preclinical research by Mater...Read more
Article
Largest microarray patch clinical vaccination study ever performed Immune response significantly higher, faster Vaccine shown to be stable for 12 months at temperatures as high as 40 o C Vaxxas...Read more
Article
TRI-based researchers from The University of Queensland (UQ) were involved in discovering how joint inflammation evolves in rheumatoid arthritis, and the cells that prolong the inflammatory attack...Read more
Article
Reduced immune infiltration into nodes associated with poor outcomes in follicular lymphoma Research published today in the highly prestigious Journal of Clinical Oncology by Mater Research CEO and...Read more
Article
Can a patient’s own immune cells be modified to cure a rare and deadly type of lymphoma? Professor Maher Gandhi, CEO of Mater Research and Director of Mater Research Institute-UQ, is leading a...Read more
Article
Over $5.9 million in NHMRC funding awarded to TRI-based researchers for 2019 In the latest round of NHMRC funding announced this month, TRI-based researchers from UQ, QUT and Mater-UQ have secured...Read more
Article
Early bird registration open for APLAR-ARA 2019 Are you working in research areas relevant to rheumatology such as pain, autoimmune diseases, bone and joint diseases, inflammation, and immunology? Do...Read more
Article
A global front runner in cervical cancer prevention: Australia on track to eliminate cervical cancer by 2035 New research published today has revealed that cervical cancer may be eliminated as a...Read more
Event
immunology seminar series Australasian Society for Immunology Invited International Speaker Joel Ernst, MD Professor and Chief, Division of Experimental Medicine University of California, San...Read more
Article
Dendright announces first human dose of DEN-181 in phase 1b Clinical Trial Dendright Pty Limited, a clinical-stage biotechnology company developing a first-in-class immunotherapy for the treatment of...Read more

Pages